Atos SE (WBO:ATO)
€ 0.6578 -0.0054 (-0.81%) Market Cap: 73.11 Mil Enterprise Value: 5.17 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 52/100

Half Year 2024 Atos SE Earnings Call Transcript

Aug 01, 2024 / 06:00AM GMT
Release Date Price: €1 (-0.65%)

Key Points

Positve
  • Atos SE (AEXAF) has secured an agreement with financial creditors, ensuring ample liquidity and no debt maturing before the end of 2029.
  • The company successfully delivered the UEFA EURO football club and is fully mobilized for the Paris Olympic and Paralympic Games.
  • Atos SE (AEXAF) achieved an 88% success rate on contract renewals, demonstrating strong customer confidence.
  • The company is investing in future growth, prioritizing client capital expenditure and R&D.
  • Headcount adjustments and lower attrition rates indicate effective workforce management.
Negative
  • Group revenue decreased by 2.7% organically compared to the first half of 2023.
  • Operating margin declined to 2.3% of revenue, down from 3.3% in H1 2023.
  • Free cash flow was negative at EUR1.9 billion for the first half of 2024.
  • Revenue in the Americas decreased by 6.9% organically, reflecting a market slowdown.
  • Net loss group share was EUR1.1 billion, impacted by goodwill and other intangible impairment charges.
Jean Pierre Mustier
Atos SE - Chairman & CEO

Good morning to everybody. Thank you for joining us to discuss our half year 2024 result on the call today and will be I can tell you that our June do our group CO. as well as project costs, where do we pay our group CFO.

Before we start, I just want to draw your attention to the customary disclaimer that you find on the slide now for the agenda. And I will share some key messages related to our first half 2024. Then Carlo will cover in more details our performance by lines of business and region. And then Jean-Francois will go over our financial statement for the half year. And then I will come back with closing remarks and we will take your questions.

As far as some of the highlights of the semester are concerned. First, the opening of the accelerated safeguard proceedings by the commercial court last week marks another important step in i2's financial restructuring process. In three words, Aptose is safe. We now have an agreement with our financial creditors that secures the financing for the short and long term and provides ample

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot